FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Comments Sought on Graphic Health Warnings

Federal Register notice: FDA requests public comments on a new information collection related to a proposed Experimental Study on Warning Statements f...

Human Drugs

Appeals Court Sends Fosamax Case Back to Lower Court

The 3rd Circuit Appeals Court sends hundreds of plaintiffs claims against Mercks Fosamax back to a district court because the claims are not preempted...

Human Drugs

Report Questions Industry Argument on High Drug Prices

As Congress and president Trump pledge to address skyrocketing drug costs, a new report by consumer advocacy group Public Citizen calls into question ...

FDA General

Pew Report Calls for Better Data on Antibiotic Use

A new report by Pew Charitable Trusts says that currently available data on antibiotic use in the U.S. are insufficient.

FDA General

Confirmation Hearing on Gottlieb to be Planned Soon

Senate Health, Education, Labor & Pension committee chair Lamar Alexander (R-TN) says a confirmation hearing will be scheduled soon after the committe...

Medical Devices

iCAD PMA Approved for Breast Imaging Aid

FDA approves an iCAD PMA for its PowerLook Tomo Detection device, a concurrent-read computer aided detection product for digital breast 3D tomosynthes...

Human Drugs

FDA Rejects Osmotica Petition on Venlafaxine Bioequivalence

FDA denies an Osmotica Pharmaceutical petition asking the agency to require that any ANDA seeking approval of venlafaxine HCl extended-release tablets...

Human Drugs

FDA Denies Sandoz Petition on Generic Advair

FDA denies a 10/2016 Sandoz citizen petition that asked FDA not to approve generic copies of GlaxoSmithKlines asthma inhaler Advair Diskus 100/50 (flu...

FDA General

Trumps Budget for FDA Could Risk Agency Collapse

FDA Webview editor Jim Dickinson analyzes what is known about the Trump budget proposals intentions for FDA and says they risk the collapse of the age...

Human Drugs

FDA Approves Tesaros Ovarian Cancer Drug

FDA approves a Tesaro, Inc. NDA for Zejula (niraparib) for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tu...